Pathological findings of COVID-19 associated with acute respiratory distress syndrome

Xu, Zhe, Shi, Lei, Wang, Yijin, Zhang, Jiyuan, Huang, Lei, Zhang, Chao, Liu, Shuhong, Zhao, Peng +10 more·2020·The Lancet Respiratory Medicine
DOI 10.1016/s2213-2600(20)30076-x

Cited by (1,023)

Items 301–400 of 1,023

  1. Elevated Troponin in Patients With Coronavirus Disease 2019: Possible Mechanisms
    Gregorio Tersalvi, Marco Vicenzi, Davide Calabretta, Luigi Biasco, Giovanni Battista Pedrazzini, Dario Winterton · 2020 · Journal of Cardiac Failure
  2. Pulmonary and systemic involvement in COVID‐19 patients assessed with ultrasound‐guided minimally invasive autopsy
    Amaro Nunes Duarte‐Neto, Renata Aparecida de Almeida Monteiro, Luiz Fernando Ferraz da Silva, Denise Maria Avancini Costa Malheiros, E.P. Oliveira, Jair Theodoro Filho, João Renato Rebello Pinho, Michele Soares Gomes‐Gouvêa, Ana Paula Moreira Salles, Ilka Regina Souza de Oliveira et al. · 2020 · Histopathology
  3. Clinical remission of a critically ill COVID-19 patient treated by human umbilical cord mesenchymal stem cells
    Bing Liang, Junhui Chen, Tao Li, Haiying Wu, Wenjie Yang, Yanjiao Li, Jianchun Li, Congtao Yu, Fangang Nie, Zhaoxia Ma et al. · 2020 · Medicine
  4. The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong?
    Dounia Darif, Ikram Hammi, Ayyoub Kihel, Imane El Idrissi Saik, Fadila Guessous, Khadija Akarid · 2021 · Microbial Pathogenesis
  5. Association between platelet parameters and mortality in coronavirus disease 2019: Retrospective cohort study
    Yanli Liu, Wenwu Sun, Yanan Guo, Liangkai Chen, Lijuan Zhang, Zhao Su, Ding Long, Li Yu · 2020 · Platelets
  6. Erratum To: Syncytia formation by SARS‐CoV‐2‐infected cells
    Julian Buchrieser, Jérémy Dufloo, Mathieu Hubert, Blandine Monel, Delphine Planas, Maaran Michael Rajah, Cyril Planchais, Françoise Porrot, Florence Guivel‐Benhassine, Sylvie van der Werf et al. · 2021 · The EMBO Journal
  7. Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial
    Fanping Meng, Ruonan Xu, Siyu Wang, Zhe Xu, Chao Zhang, Yuanyuan Li, Tao Yang, Lei Shi, Junliang Fu, Tianjun Jiang et al. · 2020 · Signal Transduction and Targeted Therapy
  8. Coronavirus Disease 2019 in Geriatrics and Long‐Term Care: The ABCDs of COVID ‐19
    Heather D’Adamo, Thomas T. Yoshikawa, Joseph G. Ouslander · 2020 · Journal of the American Geriatrics Society
  9. Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion
    Guido Papa, Donna L. Mallery, Anna Albecka, Lawrence G. Welch, Jérôme Cattin‐Ortolá, Jakub Lupták, David Paul, Harvey T. McMahon, Ian Goodfellow, Andrew P. Carter et al. · 2021 · PLoS Pathogens
  10. A Potential Role of Interleukin 10 in COVID-19 Pathogenesis
    Ligong Lu, Hui Zhang, Danielle J. Dauphars, You-Wen He · 2020 · Trends in Immunology
  11. Pulmonary pathology of ARDS in COVID-19: A pathological review for clinicians
    Batah, Sabrina Setembre, Fabro, Alexandre Todorovic · 2021 · Respiratory Medicine
  12. Follow up of patients with severe coronavirus disease 2019 (COVID-19): Pulmonary and extrapulmonary disease sequelae
    Ayham Daher, Paul Balfanz, Christian Gabriel Cornelissen, Annegret Müller, Ingmar Bergs, Nikolaus Marx, Dirk Müller‐Wieland, Bojan Hartmann, Michael Dreher, Tobias Müller · 2020 · Respiratory Medicine
  13. Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence
    Yuchen Cao, Qixin Deng, Shixue Dai · 2020 · Travel Medicine and Infectious Disease
  14. Early prediction of disease progression in COVID-19 pneumonia patients with chest CT and clinical characteristics
    Zhichao Feng, Qizhi Yu, Shanhu Yao, Lei Luo, Wenming Zhou, Xiaowen Mao, Jennifer S.Y. Li, Junhong Duan, Zhimin Yan, Min Hee Yang et al. · 2020 · Nature Communications
  15. Autoinflammatory and autoimmune conditions at the crossroad of COVID-19
    Yhojan Rodríguez, Lucia Novelli, Manuel Rojas, Maria De Santis, Yeny Acosta‐Ampudia, Diana M. Monsalve, Carolina Ramı́rez-Santana, Antonio Costanzo, William M. Ridgway, Aftab Ahmed Ansari et al. · 2020 · Journal of Autoimmunity
  16. Prognostic value of NT-proBNP in patients with severe COVID-19
    Lei Gao, Dan Jiang, Xuesong Wen, Xiaocheng Cheng, Min Jung Sun, Bin He, Linna You, Lei Peng, Xiao‐Wei Tan, Shu Qin et al. · 2020 · Respiratory Research
  17. COVID-19 and Cancer: Lessons From a Pooled Meta-Analysis
    Aakash P. Desai, Sonali Sachdeva, Tarang Parekh, Rupak Desai · 2020 · JCO Global Oncology
  18. Could SARS-CoV-2-Induced Hyperinflammation Magnify the Severity of Coronavirus Disease (CoViD-19) Leading to Acute Respiratory Distress Syndrome?
    A. S. Smiline Girija, Esaki Muthu Shankar, Marie Larsson · 2020 · Frontiers in Immunology
  19. From SARS to SARS-CoV-2, insights on structure, pathogenicity and immunity aspects of pandemic human coronaviruses
    Nikhil Kirtipal, Shiv Bharadwaj, Sang Gu Kang · 2020 · Infection Genetics and Evolution
  20. Comparison of nonhuman primates identified the suitable model for COVID-19
    Shuaiyao Lu, Yuan Zhao, Wenhai Yu, Yun Yang, Jiahong Gao, Junbin Wang, Dexuan Kuang, Mengli Yang, Jing Yang, Chunxia Ma et al. · 2020 · Signal Transduction and Targeted Therapy
  21. Potential intestinal infection and faecal–oral transmission of SARS-CoV-2
    Meng Guo, Wanyin Tao, Richard Anthony Flavell, Shu Zhu · 2021 · Nature Reviews Gastroenterology & Hepatology
  22. Analysis of clinical characteristics and laboratory findings of 95 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a retrospective analysis
    Gemin Zhang, Jie Zhang, Bowen Wang, Xionglin Zhu, Qiang Wang, Shiming Qiu · 2020 · Respiratory Research
  23. Pulmonary pathology and COVID-19: lessons from autopsy. The experience of European Pulmonary Pathologists
    Fiorella Calabrese, Federica Pezzuto, Francesco Fortarezza, Paul M Hofman, Izidor Kern, Ángel Panizo, Jan H. von der Thüsen, Sergei Timofeev, Gregor Gorkiewicz, Francesca Lunardi · 2020 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  24. Preventive and therapeutic benefits of nelfinavir in rhesus macaques and human beings infected with SARS-CoV-2
    Zhijian Xu, Danrong Shi, Jian-Bao Han, Yun Ling, Xiangrui Jiang, Xiangyun Lu, Chuan Li, Likun Gong, Guangbo Ge, Yani Zhang et al. · 2023 · Signal Transduction and Targeted Therapy
  25. Prediction model and risk scores of ICU admission and mortality in COVID-19
    Zirun Zhao, Anne L. Chen, Wei Hou, James M. Graham, Haifang Li, Paul S. Richman, Henry C. Thode, Adam J. Singer, Timothy Q. Duong · 2020 · PLoS ONE
  26. AGA Rapid Recommendations for Gastrointestinal Procedures During the COVID-19 Pandemic
    Shahnaz Sultan, Joseph K. Lim, Osama Altayar, Perica Davitkov, Joseph D. Feuerstein, Shazia Mehmood Siddique, Yngve T Falck-Ytter, Hashem B. El‐Serag · 2020 · Gastroenterology
  27. Profile of Immunoglobulin G and IgM Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
    Jiuxin Qu, Chi Wu, Xiaoyong Li, Guobin Zhang, Zhaofang Jiang, Xiaohe Li, Qing Zhu, Lei Liu · 2020 · Clinical Infectious Diseases
  28. Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: a review of current evidence
    Sayeeda Rahman, Maria Teresa Villagomez Montero, Kherie Rowe, Rita Kirton, Frank Kunik · 2021 · Expert Review of Clinical Pharmacology
  29. Pulmonary Angiopathy in Severe COVID-19: Physiologic, Imaging, and Hematologic Observations
    Brijesh V. Patel, Deepa J. Arachchillage, Carole A. Ridge, Paolo Bianchi, James F. Doyle, Benjamin E. Garfield, Stéphane Ledot, Cliff Morgan, Maurizio Passariello, Susanna Price et al. · 2020 · American Journal of Respiratory and Critical Care Medicine
  30. A Large-Scale COVID-19 Twitter Chatter Dataset for Open Scientific Research—An International Collaboration
    Juan M. Banda, Ramya Tekumalla, Guanyu Wang, Jingyuan Yu, Tuo Liu, Yuning Ding, Ekaterina Artemova, Elena Viktorovna Tutubalina, Gerardo Chowell · 2021 · Epidemiologia
  31. Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?
    Konstantinos E. Farsalinos, Anastasia Barbouni, RAYMOND S. NIAURA · 2020 · Internal and Emergency Medicine
  32. Current status of probiotic and related health benefits
    Tridip Kumar Das, Shrabani Pradhan, Sudipta Chakrabarti, Keshab Chandra Mondal, Kuntal Ghosh · 2022 · Applied Food Research
  33. Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19
    Wei Luo, Yixin Li, Lijun Jiang, Qian Chen, Tao Wang, Dawei Ye · 2020 · Trends in Pharmacological Sciences
  34. Innate immune and inflammatory responses to SARS-CoV-2: Implications for COVID-19
    Shearon A. Lowery, A. Sariol, S. Perlman · 2021 · Cell Host and Microbe
  35. Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies
    Florian A. Lempp, Leah B. Soriaga, Martin Montiel-Ruiz, Fabio Benigni, Julia Noack, Young‐Jun Park, Siro Bianchi, Alexandra C. Walls, John E. Bowen, Jiayi Zhou et al. · 2021 · Nature
  36. COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort study
    Jessica J. Manson, Colin John Crooks, Meena Naja, Amanda Ledlie, Bethan Goulden, Trevor Liddle, Emon Khan, Puja Mehta, Lucia Martin‐Gutierrez, Kirsty E. Waddington et al. · 2020 · The Lancet Rheumatology
  37. Hypofibrinolytic state and high thrombin generation may play a major role in SARS‐COV2 associated thrombosis
    Christophe Nougier, Rémi Benoit, Marie Simon, Helene Desmurs‐Clavel, Guillaume Marcotte, Laurent Argaud, Jean David, A. Bonnet, Claude Négrier, Yesim G. Dargaud · 2020 · Journal of Thrombosis and Haemostasis
  38. Unspecific post-mortem findings despite multiorgan viral spread in COVID-19 patients
    Myriam Remmelink, Ricardo De Mendonça, Nicky D’Haene, Sarah De Clercq, Camille Verocq, Laetitia Lebrun, Philomène Lavis, Marie-Lucie Racu, Anne‐Laure Trépant, Calliope Maris et al. · 2020 · Critical Care
  39. Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection
    Zhila Maghbooli, Mohammad Ali Sahraian, Mehdi Ebrahimi, Marzieh Pazoki, Samira Kafan, Hedieh Moradi Tabriz, Azar Hadadi, Mahnaz Montazeri, Mehrad Nasiri, Arash Shirvani et al. · 2020 · PLoS ONE · Retracted
  40. COVID‐19 and the Otolaryngologist: Preliminary Evidence‐Based Review
    Neelaysh Vukkadala, Zhen Jason Qian, F. Christopher Holsinger, Zara M. Patel, Eben Lloyd Rosenthal · 2020 · The Laryngoscope
  41. What motivates Chinese consumers to avoid information about the COVID-19 pandemic?: The perspective of the stimulus-organism-response model
    Shijie Song, Xinlin Yao, Nainan Wen · 2020 · Information Processing & Management
  42. Body Localization of ACE-2: On the Trail of the Keyhole of SARS-CoV-2
    Francesca Salamanna, Melania Maglio, Maria Paola Landini, Milena Fini · 2020 · Frontiers in Medicine
  43. Current status of potential therapeutic candidates for the COVID-19 crisis
    Jiancheng Zhang, Bing Xie, Kenji Hashimoto · 2020 · Brain Behavior and Immunity
  44. COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up
    Amir Tajbakhsh, Seyed Mohammad Gheibi Hayat, Hajar Taghizadeh, Ali Akbari, Masoumeh inabadi, Amir Savardashtaki, Thomas Patrick Johnston, Amirhossein Sahebkar · 2020 · Expert Review of Anti-infective Therapy
  45. SARS-CoV-2 infection induces the dedifferentiation of multiciliated cells and impairs mucociliary clearance
    Rémy Robinot, Mathieu Hubert, Guilherme Dias de Melo, Françoise Lazarini, Timothée Bruel, Nikaïa Smith, Sylvain Levallois, Florence Larrous, Julien Fernandes, Stacy Gellenoncourt et al. · 2021 · Nature Communications
  46. Delayed production of neutralizing antibodies correlates with fatal COVID-19
    Carolina Gonçalves de Oliveira Lucas, Jon Klein, Maria E. Sundaram, Feimei Liu, Patrick Wong, Júlio Dos Santos Silva, Tianyang Mao, Ji Eun Oh, Subhasis Mohanty, Jiefang Huang et al. · 2021 · Nature Medicine
  47. In situ detection of SARS-CoV-2 in lungs and airways of patients with COVID-19
    Inga‐Marie Schaefer, Robert F. Padera, Isaac H. Solomon, Sanjat Kanjilal, Mark Morris Hammer, Jason L. Hornick, Lynette Marie Sholl · 2020 · Modern Pathology
  48. Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial
    Lei Shi, Hai Huang, Xue-Chun Lu, Xiaoyan Yan, Xiaojing Jiang, Ruonan Xu, Siyu Wang, Chao Zhang, Xin Yuan, Zhe Xu et al. · 2021 · Signal Transduction and Targeted Therapy
  49. METTL3 regulates viral m6A RNA modification and host cell innate immune responses during SARS-CoV-2 infection
    Na Li, Hui Hui, Bill Bray, Gwendolyn Michelle Gonzalez, Mark Zeller, Kristian G. Anderson, Rob D. Knight, Davey Mitchell Smith, Yinsheng Wang, Aaron F. Carlin et al. · 2021 · Cell Reports
  50. Extrapulmonary manifestations of COVID-19: Radiologic and clinical overview
    Shima Behzad, Leila Aghaghazvini, Amir Reza Radmard, Ali Gholamrezanezhad · 2020 · Clinical Imaging
  51. Clinical and pathological investigation of patients with severe COVID-19
    Shaohua Li, Lina Jiang, Xi Li, Fang Lin, Yijin Wang, Boan Li, Tianjun Jiang, Weimin An, Shuhong Liu, Hongyang Liu et al. · 2020 · JCI Insight
  52. COVID–19-associated coagulopathy: An exploration of mechanisms
    Meaghan E. Colling, Yogendra M. Kanthi · 2020 · Vascular Medicine
  53. COVID-19 vaccine: A recent update in pipeline vaccines, their design and development strategies
    Kajal Rawat, Puja Kumari, Lekha Saha · 2020 · European Journal of Pharmacology
  54. STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters
    Robbert Boudewijns, Hendrik Jan Thibaut, Suzanne J. F. Kaptein, Rong Li, Valentijn Vergote, Laura Seldeslachts, Johan Van Weyenbergh, Carolien De Keyzer, Lindsey Bervoets, Sapna Sharma et al. · 2020 · Nature Communications
  55. Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study
    Noa Biran, Andrew Ip, Jaeil Ahn, Ronaldo Collo Go, Shuqi Wang, Shivam Mathura, Brittany Sinclaire, Urszula Bednarz, Michael Marafelias, Eric Hansen et al. · 2020 · The Lancet Rheumatology
  56. COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?
    Serena Colafrancesco, Cristiano Alessandri, Fabrizio Conti, Roberta Priori · 2020 · Autoimmunity Reviews
  57. Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID‐19
    Claire S. Whyte, Gael B. Morrow, Joanne L. Mitchell, Pratima Chowdary, Nicola J. Mutch · 2020 · Journal of Thrombosis and Haemostasis
  58. A brief review of socio-economic and environmental impact of Covid-19
    Muhammad Farhan Bashir, Benjiang Ma, Luqman Shahzad · 2020 · Air Quality Atmosphere & Health
  59. Post-COVID-19 Syndrome: The Persistent Symptoms at the Post-viral Stage of the Disease. A Systematic Review of the Current Data
    Francesca Salamanna, Francesca Veronesi, Lúcia Martini, Maria Paola Landini, Milena Fini · 2021 · Frontiers in Medicine
  60. Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome
    Bindu Diana Paul, Marian Dix Lemle, Anthony L. Komaroff, Solomon H. Snyder · 2021 · Proceedings of the National Academy of Sciences
  61. Impact of low dose tocilizumab on mortality rate in patients with COVID-19 related pneumonia
    Ruggero Capra, Nicola De Rossi, Flavia Mattioli, Giuseppe Romanelli, Cristina Scarpazza, Maria Pia Sormani, Stefania Cossi · 2020 · European Journal of Internal Medicine
  62. The cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart disease
    Weiyi Tan, Jamil Aboulhosn · 2020 · International Journal of Cardiology
  63. Cytokine storm and immunomodulatory therapy in COVID-19: Role of chloroquine and anti-IL-6 monoclonal antibodies
    Ming Zhao · 2020 · International Journal of Antimicrobial Agents
  64. SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes
    André Costa Ferreira, Vinícius Cardoso Soares, Isaclaudia Gomes de Azevedo-Quintanilha, Suelen da Silva Gomes Dias, Natalia Fintelman Rodrigues, Carolina Q. Sacramento, Mayara Mattos, Caroline Souza de Freitas, Jairo Ramos Temerozo, Lívia Teixeira et al. · 2021 · Cell Death Discovery
  65. Multiple organ dysfunction in SARS-CoV-2: MODS-CoV-2
    Chiara Robba, Denise Battaglini, Paolo P. Pelosi, Patrícia R. M. Rocco · 2020 · Expert Review of Respiratory Medicine
  66. Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients
    Timothée Klopfenstein, Souheil Zayet, Anne Lohse, J.-C. Balblanc, Julio C Badie, P.-Y. Royer, L. Toko, Chaouki Mezher, N’dri Juliette Kadiane-Oussou, Marie Bossert et al. · 2020 · Médecine et Maladies Infectieuses
  67. Elevated plasma levels of selective cytokines in COVID-19 patients reflect viral load and lung injury
    Yingxia Liu, Cong Zhang, Fengming Huang, Yang Yang, Fuxiang Wang, Jing Yuan, Zheng Zhang, Yuhao Qin, Xiaoyun Li, Dandan Zhao et al. · 2020 · National Science Review
  68. Liver injury in COVID‐19: The current evidence
    Saleh A. Alqahtani, Jörn Markus Schattenberg · 2020 · United European Gastroenterology Journal
  69. SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO
    Jing Wu, Yuheng Shi, Xiaoyan Pan, Shuang Wu, Ruixia Hou, Yong Zhang, Tiansheng Zhong, Hao Tang, Wei Du, Luying Wang et al. · 2021 · Cell Reports
  70. ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19
    Donato Zipeto, Julys da Fonseca Palmeira, Gustavo Adolfo Argañaraz, Enrique Roberto Argañaraz · 2020 · Frontiers in Immunology
  71. Environmental factors involved in SARS-CoV-2 transmission: effect and role of indoor environmental quality in the strategy for COVID-19 infection control
    Kenichi Azuma, U Yanagi, Naoki Kagi, Hoon Kim, Masayuki OGATA, Motoya Hayashi · 2020 · Environmental Health and Preventive Medicine
  72. Review on the potential action mechanisms of Chinese medicines in treating Coronavirus Disease 2019 (COVID-19)
    Yu‐Feng Huang, Chen Bai, Fan He, Ying Xie, Hua Zhou · 2020 · Pharmacological Research
  73. Pathophysiology of Acute Respiratory Distress Syndrome and COVID-19 Lung Injury
    Kai Erik Swenson, Erik Richard Swenson · 2021 · Critical Care Clinics
  74. Tocilizumab for the treatment of severe coronavirus disease 2019
    Rand A. Alattar, Tawheeda B. H. Ibrahim, Shahd H. Shaar, Shiema Abdalla, Kinda Shukri, Joanne Daghfal, Mohamed Y. Khatib, Mohamed Aboukamar, Mohammed Abukhattab, Hussam Al Soub et al. · 2020 · Journal of Medical Virology
  75. ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population
    Elisa Benetti, Rossella Tita, Ottavia Spiga, Andrea Ciolfi, Giovanni Birolo, Alessandro Bruselles, Gabriella Doddato, Annarita Giliberti, Caterina Marconi, Francesco Musacchia et al. · 2020 · European Journal of Human Genetics
  76. COVID-19 Sensing: Negative Sentiment Analysis on Social Media in China via BERT Model
    Tianyi Wang, Ke Lu, K. P. Chow, Qing Zhu · 2020 · IEEE Access
  77. Pathophysiology of COVID-19: Mechanisms Underlying Disease Severity and Progression
    Mary Kathryn Bohn, Alexandra Hall, Lusia Sepiashvili, Benjamin Jung, Shannon Steele, Khosrow Adeli · 2020 · Physiology
  78. ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19
    Mengzhen Dong, Jie Zhang, Xuefeng Ma, Jie Tan, Lizhen Chen, Shousheng Liu, Yongning Xin, Likun Zhuang · 2020 · Biomedicine & Pharmacotherapy
  79. The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection
    Ana Maria Copaescu, Olivia Catherine Smibert, Andrew Gibson, Elizabeth Jane Phillips, Jason Anthony Trubiano · 2020 · Journal of Allergy and Clinical Immunology
  80. Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changes
    Ravindra, Neal G., Alfajaro, Mia Madel, Gasque, Victor, Huston, Nicholas C., Wan, Han, Szigeti-Buck, Klara, Yasumoto, Yuki, Greaney, Allison M., Habet, Victoria, Chow, Ryan D. et al. · 2021 · PLOS Biology
  81. Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research
    Mahesh V. Madhavan, Behnood Bikdeli, Aakriti Gupta, David Jiménez, John Burton, Caroline A Der-Nigoghossian, Taylor Chuich, Shayan Nabavi Nouri, Isaac Dreyfus, Elissa Driggin et al. · 2020 · Thrombosis and Haemostasis
  82. Characteristics and prognostic factors of disease severity in patients with COVID-19: The Beijing experience
    Ying Sun, Yanli Dong, Lifeng Wang, Huan Xie, Baosen Li, Christopher Chia-Chi Chang, Fu‐Sheng Wang · 2020 · Journal of Autoimmunity
  83. Using Smartphones and Wearable Devices to Monitor Behavioral Changes During COVID-19
    Sun, Shaoxiong, Folarin, Amos A, Ranjan, Yatharth, Rashid, Zulqarnain, Conde, Pauline, Stewart, Callum, Cummins, Nicholas, Matcham, Faith, Dalla Costa, Gloria, Simblett, Sara et al. · 2020 · Journal of Medical Internet Research
  84. Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects
    Ya‐Wen Cheng, Tai‐Ling Chao, Chiao‐Ling Li, Mu-Fan Chiu, Han‐Chieh Kao, Sheng-Han Wang, Yu-Hao Pang, Chih-Hui Lin, Ya‐Min Tsai, Wen-Hau Lee et al. · 2020 · Cell Reports
  85. Pilot trial of high-dose vitamin C in critically ill COVID-19 patients
    Jing Zhang, Xin Rao, Yiming Li, Yuan Zhu, Fang Liu, Guangling Guo, Guoshi Luo, Zhongji Meng, Daniel De Backer, Hui Xiang et al. · 2021 · Annals of Intensive Care
  86. Role of Inflammatory Cytokines in COVID-19 Patients: A Review on Molecular Mechanisms, Immune Functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine Storm
    Ali Ahmed Rabaan, Shamsah H. Al-Ahmed, Javed Muhammad, Amjad Khan, Anupam Ashutosh Sule, Raghavendra Tirupathi, Abbas Saleh Al Mutair, Saad Alhumaid, Awad Al‐Omari, Manish K. Dhawan et al. · 2021 · Vaccines
  87. Relationship between COVID-19 and weather: Case study in a tropical country
    Denes Kaic Alves do Rosário, Yhan S. Mutz, Patrícia Campos Bernardes, Carlos Adam Conte‐Júnior · 2020 · International Journal of Hygiene and Environmental Health
  88. Federated Learning of Electronic Health Records Improves Mortality Prediction in Patients Hospitalized with COVID-19
    Vaid, Akhil, Jaladanki, Suraj K, Xu, Jie, Teng, Shelly, Kumar, Arvind, Lee, Samuel, Somani, Sulaiman, Paranjpe, Ishan, Freitas, Jessica K De, Wanyan, Tingyi et al. · 2020
  89. The role of iron in the pathogenesis of COVID-19 and possible treatment with lactoferrin and other iron chelators
    Hosam M. Habib, Sahar Ibrahim, Aamnah Zaim, Wissam H. Ibrahim · 2021 · Biomedicine & Pharmacotherapy
  90. What dentists need to know about COVID-19
    Maryam Baghizadeh Fini · 2020 · Oral Oncology
  91. Healthy movement behaviours in children and youth during the COVID-19 pandemic: Exploring the role of the neighbourhood environment
    Raktim Mitra, Sarah A. Moore, Meredith A. M. Gillespie, Guy Faulkner, Leigh M. Vanderloo, Tala Chulak-Bozzer, Ryan E. Rhodes, MARIANA J. BRUSSONI, Mark Stephen Tremblay · 2020 · Health & Place
  92. Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow’s triad
    Ahmed, Sakir, Zimba, Olena, Gasparyan, Armen Yuri · 2020 · Clinical Rheumatology
  93. CORONAVIRUS DISEASE 2019 (COVID-19): A LITERATURE REVIEW
    Bashar Ibrahım, Ebru Önem · 2021 · Gevher Nesibe Journal IESDR
  94. An analysis on the panic during COVID-19 pandemic through an online form
    Christian Jasper Nicomedes, Ronn Mikhael A. Avila · 2020 · Journal of Affective Disorders
  95. Systematic review with meta‐analysis: liver manifestations and outcomes in COVID‐19
    Anand V. Kulkarni, Pramod Kumar, Harsh Vardhan Tevethia, Madhumita Premkumar, Juan Pablo Arab, Roberto Cândia, Rupjyoti Talukdar, Mithun Sharma, Xiaolong Qi, Padaki Nagaraja Rao et al. · 2020 · Alimentary Pharmacology & Therapeutics
  96. Abnormal Liver Tests in COVID‐19: A Retrospective Observational Cohort Study of 1,827 Patients in a Major U.S. Hospital Network
    Melanie A. Hundt, Yanhong Deng, Maria M. Ciarleglio, Michael H. Nathanson, Joseph K. Lim · 2020 · Hepatology
  97. Two distinct immunopathological profiles in autopsy lungs of COVID-19
    Nienhold, Ronny, Ciani, Yari, Koelzer, Viktor H., Tzankov, Alexandar, Haslbauer, Jasmin D., Menter, Thomas, Schwab, Nathalie, Henkel, Maurice, Frank, Angela, Zsikla, Veronika et al. · 2020 · Nature Communications
  98. Elevated ACE-2 expression in the olfactory neuroepithelium: implications for anosmia and upper respiratory SARS-CoV-2 entry and replication
    Mengfei Chen, Wenjuan Shen, Nicholas R. Rowan, Heather M. Kulaga, Alexander T. Hillel, Murugappan Ramanathan, Andrew P. Lane · 2020 · European Respiratory Journal
  99. The central role of the nasal microenvironment in the transmission, modulation, and clinical progression of SARS-CoV-2 infection
    Oreste Gallo, Luca Giovanni Locatello, Alessio Mazzoni, Luca Novelli, Francesco Annunziato · 2020 · Mucosal Immunology
  100. Chemokines and chemokine receptors during COVID-19 infection
    Bariaa A. Khalil, Noha Mousaad Elemam, Azzam A. Maghazachi · 2021 · Computational and Structural Biotechnology Journal